Xopenex
NDC Package 54868-6021-0
Package Information
Xopenex is levalbuterol is used to treat wheezing and shortness of breath that commonly occur with lung problems (such as asthma, chronic obstructive pulmonary disease). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-6021 and is authorized under FDA application NDA020837.
Identification & Billing
- RxCUI: 1855389 - levalbuterol HCl concentrate 1.25 MG in 0.5 ML Inhalation Solution
- RxCUI: 1855389 - levalbuterol 2.5 MG/ML Inhalation Solution
- RxCUI: 1855389 - levalbuterol HCl 1.25 MG per 0.5 ML Inhalation Solution
- RxCUI: 1855391 - Xopenex Concentrate 1.25 MG in 0.5 ML Inhalation Solution
- RxCUI: 1855391 - levalbuterol 2.5 MG/ML Inhalation Solution [Xopenex]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-6021 - Xopenex
- 54868-6021-0 - 30 POUCH in 1 CARTON / 1 VIAL in 1 POUCH / .5 mL in 1 VIAL
- 54868-6021 - Xopenex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-6021-0 identifies a specific commercial package of 30 pouch in 1 carton / 1 vial in 1 pouch / .5 ml in 1 vial of Xopenex, labeled by Physicians Total Care, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on April 21, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Levalbuterol is used to treat wheezing and shortness of breath that commonly occur with lung problems (such as asthma, chronic obstructive pulmonary disease). It is a quick-relief drug. Controlling these symptoms can decrease time lost from work or school. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868602100. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.